| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/01/1999 | CA2242311A1 Novel compounds |
| 02/28/1999 | CA2241427A1 Novel pyrr homolog |
| 02/28/1999 | CA2241424A1 Novel ftsy |
| 02/28/1999 | CA2241420A1 Novel folc |
| 02/28/1999 | CA2241400A1 Ftsy |
| 02/27/1999 | CA2233681A1 Novel div1b |
| 02/26/1999 | CA2241431A1 Novel spoiiie |
| 02/26/1999 | CA2241410A1 Pth |
| 02/25/1999 | WO1999009194A1 Recombinant celo avian adenovirus and use as vaccinating vector |
| 02/25/1999 | WO1999009186A2 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis |
| 02/25/1999 | WO1999009179A2 Antigen constructs useful in the detection and differentiation of antibodies to hiv |
| 02/25/1999 | WO1999009177A2 Papilloma virus, agents for the detection thereof and for the therapy of the diseases caused by said virus |
| 02/25/1999 | WO1999009176A1 Neisseria lactoferrin binding protein |
| 02/25/1999 | WO1999009171A1 Ubc7-like ubiquitin-conjugating enzyme |
| 02/25/1999 | WO1999009164A1 Coding sequence haplotypes of the human brca2 gene |
| 02/25/1999 | WO1999009162A2 Delayed progression to aids by a missense allele of the ccr2 gene |
| 02/25/1999 | WO1999009156A2 Protease-related protein |
| 02/25/1999 | WO1999009152A1 Human frezzled-like protein |
| 02/25/1999 | WO1999009146A1 Human serum inducible kinase (snk) |
| 02/25/1999 | WO1999009140A1 Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof |
| 02/25/1999 | WO1999009139A1 Retrovirus and viral vectors |
| 02/25/1999 | WO1999009064A1 Epitope-bearing major histocompatibility complex class ii element/immunoglobulin chimeric molecules |
| 02/25/1999 | WO1999009054A2 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders |
| 02/25/1999 | WO1999009049A1 Hypoxia-regulated genes |
| 02/25/1999 | WO1999009046A1 Hypoxia-regulated genes |
| 02/25/1999 | WO1999008708A2 Method and food product for increasing muscle protein and reducing fat in animals |
| 02/25/1999 | WO1999008706A1 Recombinant porcine adenovirus vector |
| 02/25/1999 | WO1999008705A1 Capsular polysaccharides from enterococci |
| 02/25/1999 | WO1999008704A1 Method of protecting against chronic infections |
| 02/25/1999 | WO1999008703A1 Anti-viral treatment with pertussis toxin b oligomer |
| 02/25/1999 | WO1999008689A1 Mucosal immunization using particle-mediated delivery techniques |
| 02/25/1999 | WO1999008539A1 Novel phytase |
| 02/25/1999 | WO1998052582A3 Non-myeloablative tolerogenic treatment |
| 02/25/1999 | WO1998046243A3 Pharmaceutical compositions having appetite suppressant activity |
| 02/25/1999 | DE19756214C1 New chimeric human cytomegalovirus (HCMV) polypeptides |
| 02/25/1999 | CA2301374A1 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis |
| 02/25/1999 | CA2301332A1 Neisseria lactoferrin binding protein |
| 02/25/1999 | CA2300957A1 Retrovirus and viral vectors |
| 02/25/1999 | CA2300918A1 Ubc7-like ubiquitin-conjugating enzyme |
| 02/25/1999 | CA2300431A1 Anti-viral treatment with pertussis toxin b oligomer |
| 02/25/1999 | CA2300390A1 Human frezzled-like protein |
| 02/25/1999 | CA2300093A1 Delayed progression to aids by a missense allele of the ccr2 gene |
| 02/25/1999 | CA2299291A1 Method and food product for increasing muscle protein and reducing fat in animals |
| 02/25/1999 | CA2298866A1 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders |
| 02/25/1999 | CA2298540A1 Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof |
| 02/25/1999 | CA2241430A1 Novel murb |
| 02/25/1999 | CA2241403A1 Murb |
| 02/25/1999 | CA2241392A1 Pigr-2, a member of immunoglobulin gene superfamily |
| 02/25/1999 | CA2241390A1 Pigrl-1, a member of immunoglobulin gene superfamily |
| 02/25/1999 | CA2239260A1 Human disintegrin metalloprotease related to drosophila kuz gene |
| 02/24/1999 | EP0897986A2 Aspartic proteinase 5 (ASP5) |
| 02/24/1999 | EP0897983A2 Antibody against CD40-L |
| 02/24/1999 | EP0897982A2 Sodium bicarbonate co-transporter |
| 02/24/1999 | EP0897981A1 Pigr-1, a member of immunoglobulin gene superfamily |
| 02/24/1999 | EP0897980A2 CXCR4B: A human splice variant of CXCR4 chemokine receptor |
| 02/24/1999 | EP0897979A2 Human sdr2 cdna clone |
| 02/24/1999 | EP0897427A1 Polysaccharide precipitation process |
| 02/24/1999 | EP0897426A1 Matrix metalloprotease |
| 02/24/1999 | EP0700440B1 Regulator of contact-mediated hemolysin |
| 02/24/1999 | EP0597101B1 STABILIZED HUMAN MONOCLONAL CLN-IgG ANTIBODY PREPARATION |
| 02/24/1999 | EP0439542B1 Filamentous hemagglutinin of b. pertussis |
| 02/24/1999 | CN1209067A Stabilisers for live vaccines |
| 02/24/1999 | CN1208769A Synthesis and clone of composite polyvalent vaccine gene for type-C hepatitis virus |
| 02/24/1999 | CN1208732A Anti Bacillus pyocyaneu Flugge vitelline immunoglobulin products and use thereof |
| 02/24/1999 | CN1042198C Multile emulsions |
| 02/23/1999 | US5874566 Il-15 triplex oligonucleotides |
| 02/23/1999 | US5874565 Nucleic acids comprising a highly conserved novel 3 terminal sequence element of the hepatitis C virus |
| 02/23/1999 | US5874561 DNA, host cell and vector encoding a protein with cytokine inhibitory activity |
| 02/23/1999 | US5874560 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 02/23/1999 | US5874552 For solid state oligonucleotide synthesis |
| 02/23/1999 | US5874544 Antibodies to APO(A) |
| 02/23/1999 | US5874543 Platelet factor 4; antiinflammatory agent |
| 02/23/1999 | US5874542 Single chain antibodies specific to VEGF receptors |
| 02/23/1999 | US5874541 Immunoglobulin or fragment is modified such that heavy chain variable region have been replaced by specific sequence or amino acids of a heavy chain immunogloblin comprising two heavy polypeptide chain consisting of antigen binding site |
| 02/23/1999 | US5874540 CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies |
| 02/23/1999 | US5874539 Antibodies to nuclear matrix proteins |
| 02/23/1999 | US5874533 HIV-2 envelope polypeptides |
| 02/23/1999 | US5874531 Polypeptides implicated as self epitope in autoimmune disease pemphigus vulgaris and multiple scelerosis |
| 02/23/1999 | US5874527 Plasmodium vivax blood stage antigens |
| 02/23/1999 | US5874526 Toxoplasma gondii antigens |
| 02/23/1999 | US5874409 Antiphospholipid analog specifically binds antibodies produced by b cells specific for an antiphospholipid epitope and lacks t cell epitopes; where in the analog is a oligopeptide or polypeptide |
| 02/23/1999 | US5874401 Cedar pollen protein and use thereof in treating, preventing, and diagnosing pollenosis |
| 02/23/1999 | US5874399 Progenitor B cell stimulating factor |
| 02/23/1999 | US5874307 Process for induction culture of cytotoxic T lymphocytes having killing activity against tumor cells |
| 02/23/1999 | US5874303 Sustainable cell line for the production of Marek's disease vaccines |
| 02/23/1999 | US5874300 Campylobacter jejuni antigens and methods for their production and use |
| 02/23/1999 | US5874287 Mutagenized DNA molecules encoding modified subunit a of Cholera-toxin |
| 02/23/1999 | US5874286 Tumor proteins |
| 02/23/1999 | US5874279 Recombinant infectious bovine rhinotracheitis virus |
| 02/23/1999 | US5874273 Nucleic acids for encoding genes and amino acid sequences and hybridization and nucleotide sequences |
| 02/23/1999 | US5874267 Expression of surface layer proteins |
| 02/23/1999 | US5874252 Splicing variant of the Epstein-Barr virus-induced G-protein coupled receptor |
| 02/23/1999 | US5874250 DNA encoding for a protein containing the extracellular domain of lymphocyte activation gene 3 |
| 02/23/1999 | US5874243 OLRCC15 receptor |
| 02/23/1999 | US5874228 Methods and kits for determining the levels of IGE-BF |
| 02/23/1999 | US5874209 Regulation of transcription factor, NF-IL6/LAP |
| 02/23/1999 | US5874099 Methods for making immunoisolatary implantable vehicles with a biocompatible jacket and a biocompatible matrix core |
| 02/23/1999 | US5874089 Protecting against canine oral papillomavirus (copy) |
| 02/23/1999 | US5874087 Modified plant viruses as vectors |
| 02/23/1999 | US5874085 A drug comprising at least one cytokine stimulants and a b cell activator selected from a cell surface protein and bacterial lipopolysaccharide |